From October 1, 2021 to December 31, 2021, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 4,139,200 shares, representing 0.67% for CNY 50.95 million under the buyback announced on March 15, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.5 CNY | -1.96% | +5.63% | -29.69% |
05-20 | Wanbangde Pharmaceutical Holding Group Co., Ltd. Approves Dividend for the Year 2023 | CI |
05-08 | US FDA Gives Rare Pediatric Disease Drug Designation to Wanbangde Pharmaceutical's Huperzine A | MT |
1st Jan change | Capi. | |
---|---|---|
-29.69% | 380M | |
+20.14% | 43.39B | |
+19.46% | 22.01B | |
+18.92% | 15.46B | |
+24.51% | 14.93B | |
+60.78% | 13.13B | |
-0.05% | 6.79B | |
-14.61% | 6.36B | |
-8.87% | 5.73B | |
+10.57% | 5.43B |
- Stock Market
- Equities
- 002082 Stock
- News Wanbangde Pharmaceutical Holding Group Co., Ltd.
- Tranche Update on Wanbangde Pharmaceutical Holding Group Co., Ltd.'s Equity Buyback Plan announced on March 15, 2021.